Featuring: Advocate Expert, Sarah Pilacik
Description: Shining a spotlight on the impact of copay accumulators and maximizers: a call for federal protections to ensure access to essential medications for patients with rare diseases.
Discussion Questions:
- How can federal legislation like H.R.830 effectively address the challenges posed by copay accumulators and maximizers for individuals with bleeding disorders and other high-cost medications?
- What role should federal agencies play in regulating and monitoring copay accumulator and maximizer programs to ensure they do not unfairly burden patients or restrict access to essential medications?
- What are some potential barriers or challenges to implementing federal protections against copay accumulators and maximizers, and how can these be addressed to ensure effective policy enforcement?